| For: | Khurana A, Hartmann P. Gut microbiome-specific nanoparticle-based therapeutics for liver diseases. World J Gastroenterol 2025; 31(27): 109105 [PMID: 40741099 DOI: 10.3748/wjg.v31.i27.109105] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i27/109105.htm |
| Number | Citing Articles |
| 1 |
Bakr Ahmed Taha, Ali J. Addie, Luai Farhan Zghair Kolie, Saba Talib Wahhab, Sinan Adnan Abdulateef, Adawiya J. Haider, Khalid Ibnaouf, Norhana Arsad. Advancements in nanophotonics and smart nanomaterials integrated with artificial intelligence-driven gene editing: A paradigm shift in cancer diagnosis and therapeutic. Chinese Chemical Letters 2026; 37(4) doi: 10.1016/j.cclet.2025.111955
|
| 2 |
Unraveling the Multifunctional and Translational Paradigm of Nanoparticulate Systems against Colorectal Cancer. ACS Applied Bio Materials 2026; 9(11) doi: 10.1021/acsabm.5c02297
|
| 3 |
Jiuba Zhang, Yanan Zhou, Xi Mei, Shuai Yan, Jing Mao, Yu Li, Zhenhua Bian, Lin Li, De Ji, Tulin Lu, Juxiang Chen, Lianlin Su. Molecular mechanisms and therapeutic potential of tryptophan metabolism in gut-brain signaling transduction: a narrative review. Journal of Neuroinflammation 2026; 23(1) doi: 10.1186/s12974-026-03763-w
|
| 4 |
Khadijah Zai. The bidirectional interface between oral drug and the gut microbiome: Implications for drug delivery. Pharmaceutical Science Advances 2026; 4 doi: 10.1016/j.pscia.2026.100112
|
| 5 |
Jing Chen, Mingliao Niu, Longjiang Zhang. Gut microbiota in hepatic encephalopathy: a 3PM-guided three-tier health strategy. EPMA Journal 2025; 17(1) doi: 10.1007/s13167-025-00433-4
|
| 6 |
Te Shi, Haiyan Yue, Wen Wang, Yu Gao, Sheng Xu, Jie Gao, Chuan Yin. Emerging Approaches for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease: The Application of Nanomedicines. International Journal of Nanomedicine 2026; doi: 10.2147/IJN.S603396
|
| 7 |
Noor Muhammad. Nanobiotic-Enhanced Probiotics for Targeted Gut Delivery: Mechanisms, Therapeutic Applications, and Translational Challenges. International Journal of Nanomedicine 2026; doi: 10.2147/IJN.S607382
|
| 8 |
Min Dai, Yisha Lin, Renyou Gan, Xiaotao Shen, Shin Young Park, Sunjae Lee, Qi Su. The Expanding Landscape of Microbiota Medicine: Indications, Therapeutic Modalities, and the Path Towards Integrative Microbiome‐Targeting Healthcare. Microbiota Medicine Research 2026; doi: 10.1002/mmr3.70004
|
| 9 |
Chun-Ye Zhang, Shuai Liu, Yu-Xiang Sui, Ming Yang. Roles of short-chain fatty acids in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis. World Journal of Hepatology 2025; 17(11): 113756 doi: 10.4254/wjh.v17.i11.113756
Abstract(71) |
Core Tip(63) |
Full Article(HTML)(582)
|
Full Article (PDF)-8919K(208)
|
Full Article with Cover (PDF)-9254K(55)
|
Full Article (XML)-301K(42)
|
Audio-183K(23)
|
Peer-Review Report-224K(39)
|
Answering Reviewers-37K(36)
|
Supplementary Material-1524K(31)
|
Times Cited (2)
|
Total Visits (1069)
|
Open
|